The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2024

Filed:

Oct. 11, 2022
Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventors:

Carol Sullivan, Litchfield Park, AZ (US);

Neil Barman, Menlo Park, CA (US);

Dwayne S. Yamasaki, St. Augustine, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 20/30 (2018.01); A61B 5/00 (2006.01); A61B 18/02 (2006.01); A61F 7/12 (2006.01); A61N 2/00 (2006.01); A61N 7/00 (2006.01); G16H 20/40 (2018.01); G16H 50/30 (2018.01); A61B 5/024 (2006.01); A61B 5/145 (2006.01); A61B 18/00 (2006.01); A61B 18/14 (2006.01); A61F 7/00 (2006.01); A61N 1/36 (2006.01); A61N 7/02 (2006.01); G16H 10/20 (2018.01);
U.S. Cl.
CPC ...
G16H 20/30 (2018.01); A61B 5/4824 (2013.01); A61B 18/0206 (2013.01); A61F 7/12 (2013.01); A61N 2/008 (2013.01); A61N 7/00 (2013.01); G16H 20/40 (2018.01); G16H 50/30 (2018.01); A61B 5/02405 (2013.01); A61B 5/14503 (2013.01); A61B 5/4035 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00345 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0262 (2013.01); A61B 18/1492 (2013.01); A61F 2007/0056 (2013.01); A61F 7/123 (2013.01); A61F 2007/126 (2013.01); A61N 1/36021 (2013.01); A61N 2007/0026 (2013.01); A61N 2007/0043 (2013.01); A61N 7/02 (2013.01); A61N 7/022 (2013.01); G16H 10/20 (2018.01); Y02A 90/10 (2018.01);
Abstract

Methods for treating and managing pain in a patient with therapeutic neuromodulation and associated systems and methods are disclosed herein. Chronic or debilitating pain can be associated, for example, with a disease or condition of the abdominal or reproductive viscera. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves proximate a target blood vessel of a diseased or damaged organ of a patient experiencing pain. Targeted sympathetic nerve activity can be modulated at least along afferent pathways which can improve a measurable parameter associated with the pain of the patient The modulation can be achieved, for example, using an intravascularly positioned catheter carrying a therapeutic assembly, e.g., a therapeutic assembly configured to use electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the target sympathetic nerve.


Find Patent Forward Citations

Loading…